Andreas Andersson - Intervacc Chief Executive Officer
| IVACC Stock | SEK 2.52 0.14 5.26% |
CEO
Mr. Andreas Andersson was Chief Executive Officer at Intervacc AB since December 13, 2018. He has previously held senior positions as CEO, General Manager and Sales Director, recently at Biolin Scientific AB. He is Civil Engineer in Industrial Economics from Linkopings universitet. since 2018.
| Tenure | 6 years |
| Phone | 46 8 12 01 06 00 |
| Web | https://www.intervacc.se |
Intervacc Management Efficiency
The company has return on total asset (ROA) of (0.0991) % which means that it has lost $0.0991 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1689) %, meaning that it generated substantial loss on money invested by shareholders. Intervacc's management efficiency ratios could be used to measure how well Intervacc manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | CEO Age | ||
| Kristian Nylen | Kambi Group PLC | 53 | |
| Hakan Lagerberg | Swedencare publ AB | 55 | |
| Hans Persson | Swedencare publ AB | 72 | |
| John Leonard | Swedencare publ AB | 58 | |
| Erik Logdberg | Kambi Group PLC | 44 | |
Management Performance
| Return On Equity | -0.17 | |||
| Return On Asset | -0.0991 |
Intervacc AB Leadership Team
Elected by the shareholders, the Intervacc's board of directors comprises two types of representatives: Intervacc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intervacc. The board's role is to monitor Intervacc's management team and ensure that shareholders' interests are well served. Intervacc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intervacc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Newton Aguiar, Director | ||
| JanIngmar Flock, CEO, Chief Scientific Officer, Director | ||
| Bert Urlings, Director | ||
| Andreas Andersson, Chief Executive Officer | ||
| Stefan Stahl, Independent Director | ||
| Rune Bergman, Chairman of the Board, Director Sales, Business Developer | ||
| Marianne Hansson, Director | ||
| Torben Joergensen, Director | ||
| Jan Persson, Chief Financial Officer | ||
| Olof Zachrisson, Director Clinical Development | ||
| Andreas Johansson, Vice President - Supply Chain Management | ||
| Bjorn Sjostrand, Chairman of the Board | ||
| Patrik Hellberg, Chief Officer | ||
| Andrew Waller, Chief Officer | ||
| Bengt Guss, Independent Director |
Intervacc Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intervacc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.17 | |||
| Return On Asset | -0.0991 | |||
| Operating Margin | (4.77) % | |||
| Current Valuation | 1.26 B | |||
| Shares Outstanding | 50.49 M | |||
| Shares Owned By Insiders | 14.49 % | |||
| Shares Owned By Institutions | 32.27 % | |||
| Price To Book | 5.02 X | |||
| Price To Sales | 125.83 X | |||
| Revenue | 5.24 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intervacc Stock Analysis
When running Intervacc's price analysis, check to measure Intervacc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intervacc is operating at the current time. Most of Intervacc's value examination focuses on studying past and present price action to predict the probability of Intervacc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intervacc's price. Additionally, you may evaluate how the addition of Intervacc to your portfolios can decrease your overall portfolio volatility.